Back to STATE STREET CORP STATE STREET CORP

VTGNVTGN
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in VISTAGEN THERAPEUTICS INC

STATE STREET CORP holds 121,114 shares of VTGN (VISTAGEN THERAPEUTICS INC), worth $27,372 as of 2026-Q2.

Current Value

$27,372

Current Shares

121,114

Total Value Change

-$227,099

Total Shares Change

+71,606

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
121,114
0.0%
$27,3720.0%$0.23
0
2026-Q1
Unchanged
121,114
0.0%
$69,2170.0%$0.61
0
2025-Q4
Increased
121,114
+25.0%
$80,1650.0%$0.68
18
2025-Q3
Unchanged
96,858
0.0%
$343,8460.0%$3.54
0
2025-Q2
Unchanged
96,858
0.0%
$193,7160.0%$1.97
0
2025-Q1
Unchanged
96,858
0.0%
$242,1450.0%$2.59
0
2024-Q4
Increased
96,858
+9.2%
$285,7310.0%$2.81
17
2024-Q3
Unchanged
88,708
0.0%
$267,0110.0%$3.07
0
2024-Q2
Increased
88,708
+6.0%
$308,7040.0%$3.48
17
2024-Q1
Increased
83,708
+69.1%
$441,9780.0%$5.28
24
2023-Q4
New
49,508
-
$254,4710.0%$5.14
35

Other major holders of VTGN: Janus Henderson Group Ltd., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used